基因分型
优势比
肺癌
医学
腺癌
基因型
癌症
肺腺癌
肿瘤科
遗传学
内科学
生物
基因
作者
Tomoaki Kahyo,Tao Hong,Kazuya Shinmura,Hidetaka Yamada,Hiroki Mori,Kazuhito Funai,Nobuya Kurabe,Masaya Suzuki,Masayuki Tanahashi,Hiroshi Niwa,Hiroshi Ogawa,Fumihiko Tanioka,Guang Yin,Makiko Morita,Keitaro Matsuo,Suminori Kono,Haruhiko Sugimura
出处
期刊:Carcinogenesis
[Oxford University Press]
日期:2013-07-19
卷期号:34 (11): 2531-2538
被引量:30
标识
DOI:10.1093/carcin/bgt253
摘要
Sequences of human endogenous retroviruses (HERVs) are members of the long terminal repeat (LTR) retrotransposon family. Although the expression of HERV has long been a topic of investigation, HERV-insertion polymorphisms are not well known, and a genetic association between HERV-insertion polymorphisms and cancer has never been reported. To identify novel HERV loci in the genome from cancer tissues, we carried out the inverse PCR method targeting a conserved LTR region of HML-2, which is the most recently acquired HERV group. Novel two insertions, HML-2_sLTR ( 1p13.2 ) and HML-2_sLTR ( 19q12 ), were identified as insertionally polymorphic solo LTRs. Furthermore, a significant prevalence of HML-2_sLTR ( 1p13.2 ) homozygosity was detected in female never-smoking patients aged 60 years and over who had lung adenocarcinoma [versus the other genotyping; odds ratio (OR): 1.97; 95% confidence interval (CI): 1.01–3.81]. In another cohort consisting of female never-smoking patients with lung adenocarcinoma, a prevalence of HML-2_sLTR ( 1p13.2 ) homozygosity tended to be high in patients aged 60 years and over (versus the other genotyping; OR: 2.03; 95% CI: 0.96–4.29), whereas a low prevalence of HML-2_sLTR ( 1p13.2 ) homozygosity was detected in patients <60 years old (versus the other genotyping; OR: 0.31; 95% CI: 0.11–0.94). Our results suggest that HML-2_sLTR ( 1p13.2 ) is involved with the susceptibility to lung adenocarcinoma in female never-smokers in an age-dependent manner and that other HERV polymorphisms related to human diseases might remain to be identified in the human genome.
科研通智能强力驱动
Strongly Powered by AbleSci AI